Remove topic quality-control-quality-assurance
article thumbnail

11th Annual Pharmaceutical Microbiology Europe Conference

pharmaphorum

Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy. This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and increased regulatory stringency, to the latest technologies in rapid microbiological testing methods and data integrity.

52
article thumbnail

Are Predetermined Change Control Plans on the road to Global Harmonization?

The FDA Law Blog

Additionally, when models are periodically or continually trained after deployment, there are appropriate controls in place to manage risks of overfitting, unintended bias, or degradation of the model (for example, dataset drift) that may impact the safety and performance of the model as it is used by the Human-AI team.

FDA 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo

ISPE

™, Quality Risk Management (QRM), Contamination Control Strategy (CCS) and Annex 1, Facility Design and Operations, Artificial Intelligence and Machine Learning, and Professional Development. The workshop Development of a Contamination Control Strategy will feature speakers from Genesis AEC and Kite Pharma, Inc.

article thumbnail

The Ever-Changing Regulatory & Quality Landscape with Aseptic Processing

ISPE

The Ever-Changing Regulatory & Quality Landscape with Aseptic Processing Trudy Patterson Mon, 01/30/2023 - 10:54 iSpeak Blog iSpeak The Ever-Changing Regulatory & Quality Landscape with Aseptic Processing Michael G. Tim Dreckmann from F. Hoffmann-La Roche Ltd. This has undoubtedly saved countless lives.

FDA 80
article thumbnail

ICH Q9 (R1): The Next Frontier

ISPE

The seminar was organized with opening keynote and plenary presentations followed by three tracks, one for each of the above topics with closing plenary sessions. The seminar was organized with opening keynote and plenary presentations followed by three tracks, one for each of the above topics with closing plenary sessions.

article thumbnail

SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients

pharmaphorum

Ensuring Risk-Based, Safety-Driven, High-Quality Operation. The conference will encompass the critical topics including risk assessment, occupational toxicology, engineering controls for containment, facility design, and the impact of pharmaceutical manufacture on the environment. SMi’s 6th Annual. 9th and 10th May 2022.

52
article thumbnail

Regulators and Industry Discuss Digital Transformation and Pharma 4.0™

ISPE

™ Thomas ZIMMER, PhD 26 June 2023 The upcoming challenges and opportunities of digital transformation were the topic of a panel discussion held on 9 May 2023 at the 2023 ISPE Europe Annual Conference in Amsterdam, The Netherlands. Furthermore, when correctly implemented, digitalization can reduce risk, and improve quality and compliance.

FDA 97